Unconventional T Cell Targets for Cancer Immunotherapy

Authors:

• Godfrey, Dale I.
• Le Nours, Jérôme
• Andrews, Daniel M.
• Uldrich, Adam P.
• Rossjohn, Jamie

Details:

Immunity, Volume 48, Issue 3, 2018-03-20

Article Link: Click here

Most studies on the immunotherapeutic potential of T cells have focused on CD8 and CD4 T cells that recognize peptide antigens (Ag) presented by polymorphic major histocompatibility complex (MHC) class I and MHC class II molecules, respectively. However, unconventional T cells, which interact with MHC class Ib and MHC-I like molecules, are also implicated in tumor immunity, although their role therein is unclear. These include unconventional T cells targeting MHC class Ib molecules such as HLA-E and its murine ortholog Qa-1b, natural killer T (NKT) cells, mucosal associated invariant T (MAIT) cells, and γδ T cells. Here, we review the current understanding of the roles of these unconventional T cells in tumor immunity and discuss why further studies into the immunotherapeutic potential of these cells is warranted.